Sekula Peggy, Li Yong, Stanescu Horia C, Wuttke Matthias, Ekici Arif B, Bockenhauer Detlef, Walz Gerd, Powis Stephen H, Kielstein Jan T, Brenchley Paul, Eckardt Kai-Uwe, Kronenberg Florian, Kleta Robert, Köttgen Anna
Department of Internal Medicine IV, Medical Center-University of Freiburg, Freiburg, Germany.
Center for Medical Biometry and Medical Informatics, Medical Center-University of Freiburg, Freiburg, Germany.
Nephrol Dial Transplant. 2017 Feb 1;32(2):325-332. doi: 10.1093/ndt/gfw001. Epub 2016 Feb 4.
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Previous genome-wide association studies (GWAS) of 300 000 genotyped variants identified MN-associated loci at HLA-DQA1 and PLA2R1.
We used a combined approach of genotype imputation, GWAS, human leucocyte antigen (HLA) imputation and extension to other aetiologies of chronic kidney disease (CKD) to investigate genetic MN risk variants more comprehensively. GWAS using 9 million high-quality imputed genotypes and classical HLA alleles were conducted for 323 MN European-ancestry cases and 345 controls. Additionally, 4960 patients with different CKD aetiologies in the German Chronic Kidney Disease (GCKD) study were genotyped for risk variants at HLA-DQA1 and PLA2R1.
In GWAS, lead variants in known loci [rs9272729, HLA-DQA1, odds ratio (OR) = 7.3 per risk allele, P = 5.9 × 10 and rs17830558, PLA2R1, OR = 2.2, P = 1.9 × 10] were significantly associated with MN. No novel signals emerged in GWAS of X-chromosomal variants or in sex-specific analyses. Classical HLA alleles (DRB10301-DQA10501-DQB1*0201 haplotype) were associated with MN but provided little additional information beyond rs9272729. Associations were replicated in 137 GCKD patients with MN (HLA-DQA1: P = 6.4 × 10; PLA2R1: P = 5.0 × 10). MN risk increased steeply for patients with high-risk genotype combinations (OR > 79). While genetic variation in PLA2R1 exclusively associated with MN across 19 CKD aetiologies, the HLA-DQA1 risk allele was also associated with lupus nephritis (P = 2.8 × 10), type 1 diabetic nephropathy (P = 6.9 × 10) and focal segmental glomerulosclerosis (P = 5.1 × 10), but not with immunoglobulin A nephropathy.
PLA2R1 and HLA-DQA1 are the predominant risk loci for MN detected by GWAS. While HLA-DQA1 risk variants show an association with other CKD aetiologies, PLA2R1 variants are specific to MN.
膜性肾病(MN)是成人肾病综合征的常见病因。先前对30万个基因分型变异进行的全基因组关联研究(GWAS)确定了HLA - DQA1和PLA2R1处与MN相关的基因座。
我们采用了基因型填充、GWAS、人类白细胞抗原(HLA)填充以及扩展至慢性肾脏病(CKD)其他病因的联合方法,以更全面地研究遗传性MN风险变异。对323例欧洲血统的MN病例和345例对照进行了使用900万个高质量填充基因型和经典HLA等位基因的GWAS。此外,对德国慢性肾脏病(GCKD)研究中4960例不同CKD病因的患者进行了HLA - DQA1和PLA2R1风险变异的基因分型。
在GWAS中,已知基因座的先导变异[rs9272729,HLA - DQA1,优势比(OR)=每个风险等位基因7.3,P = 5.9×10 ;以及rs17830558,PLA2R1,OR = 2.2,P = 1.9×10]与MN显著相关。在X染色体变异的GWAS或性别特异性分析中未出现新的信号。经典HLA等位基因(DRB10301 - DQA10501 - DQB1*0201单倍型)与MN相关,但除rs9272729外几乎未提供额外信息。在137例GCKD的MN患者中重复了这些关联(HLA - DQA1:P = 6.4×10 ;PLA2R1:P = 5.0×10)。具有高风险基因型组合的患者MN风险急剧增加(OR > 79)。虽然PLA2R1的基因变异在19种CKD病因中仅与MN相关,但HLA - DQA1风险等位基因也与狼疮性肾炎(P = 2.8×10)、1型糖尿病肾病(P = 6.9×10)和局灶节段性肾小球硬化(P = 5.1×10)相关,但与免疫球蛋白A肾病无关。
PLA2R1和HLA - DQA1是GWAS检测到的MN的主要风险基因座。虽然HLA - DQA1风险变异与其他CKD病因相关,但PLA2R1变异是MN特有的。